Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction Study of Danicopan with Warfarin, Bupropion, and Oral Contraceptives
NCT04709094Phase 1Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of danicopan in paroxysmal nocturnal hemoglobinuria (PNH) (3 arms), sponsored by Alexion Pharmaceuticals. Primary endpoints: Area Under The Concentration Versus Time Curve From Time 0 Extrapolated To Infinity, Maximum Observed Concentration and 1 more. Started Jul 2019; status: completed.
02
Drugs
danicopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT04709094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709094.